[Go to the reading](#juv-reading) [What fades](/what-fades/) [Four options](/#four-options) [Compare](/compare/) [The route](/how-it-works/) [Juventa](/) Menu [What fades](/what-fades/) [Four options](/#four-options) [Compare](/compare/) [The route](/how-it-works/) # Promise Peptides: from request to review We explain the Promise Peptides route so that a reader can distinguish the guide, the provider’s decision and the pharmacy’s part before beginning a request. [See longevity care with Promise Peptides](https://mypromise.com/solutions/anti-aging-longevity?utm_source=juventa&utm_medium=affiliate&utm_campaign=route&utm_content=how-it-works-opening) Juventa Peptides may earn money when readers become Promise patients. ## Reading and care have different jobs. Promise Peptides currently arranges prescription review through licensed U.S. providers. It is the telehealth platform, rather than the pharmacy preparing a medicine. Juventa supplies the reading and referral; Promise handles requests for care on its own site. The four options discussed here are NAD+, MOTS-c, sermorelin and GHK-Cu. They share a place in this guide because of the aging questions around them, not because they have equivalent human evidence. A consultation does not change a mouse experiment into a human result, or a changed hormone measurement into a lasting clinical benefit. ## Three steps, with a decision in the middle - 1 Begin with the question Read the relevant treatment information on Promise Peptides, then submit a request through its own site. The route serves U.S. patients, with options that depend on the state and treatment. - 2 Leave room for a decision A licensed U.S. provider at Promise reviews the request and decides whether a prescription fits. Age, interest and a completed request do not establish eligibility. - 3 Understand the preparation When prescribed, the medicine is prepared by a licensed U.S. compounding pharmacy. Compounded medicines prepared for these prescriptions are not FDA-approved, and a prescription does not turn an early research finding into an established result. ## A request is not a prescription. Every Promise request receives a licensed U.S. provider’s review. A licensed provider decides whether treatment is suitable for the person. Sending a request does not guarantee a prescription. Not everybody qualifies. A provider’s answer may be that the proposed option does not fit the person or the problem. An age-related decline does not identify the cause of a personal concern. The clinical question is more specific than “Could this level be higher?” It includes what is being evaluated, what evidence concerns that problem and whether the uncertainties leave a reasonable basis to proceed. A decision against treatment is still a medical decision. Only patients in the United States can use this Promise care route. Both the state where a patient is located and the treatment being considered affect availability. A product page is a useful starting point for information, but it cannot establish an individual reader’s eligibility or state access. ## The pharmacy has a separate role. Licensed U.S. compounding pharmacies prepare medicines prescribed through Promise. A pharmacy prepares a compounded medicine for a prescription. It is not an FDA-approved finished product, and the FDA has not reviewed each preparation’s safety, effectiveness and quality before marketing. The [FDA’s compounding explanation](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers) describes the difference between a pharmacy-prepared medicine and an approved finished product. A prescription is not a substitute for FDA approval. State licensing, an individual review and the preparation’s regulatory status are related parts of access, but they answer different questions. Sermorelin has a particular history: a former childhood approval, now withdrawn, and a basis for patient-specific compounding that depends on satisfying the relevant conditions. The [sermorelin page](/sermorelin/) explains that history. It does not make the current preparation FDA-approved or establish an adult longevity benefit. ## Certification is a different kind of credential. Promise’s LegitScript certification does not give a medicine FDA approval. It is possible to consider the service route while remaining uncertain about the treatment. That is a reasonable place to be. A provider’s role is to weigh the person and the proposed care, rather than erase unanswered scientific questions with a credential. ## Useful questions for a conversation - What concern is the proposed treatment intended to address? - Which human evidence involves this compound and this route? - What would count as a meaningful result, beyond a laboratory number? - What uncertainties or features of the health history could change the decision? Nothing in a general guide can establish an individual diagnosis. The [comparison](/compare/) is useful background, especially when two product names seem to be answering the same question. ![An adult seen from behind pausing over four unmarked bookmarks at a quiet home table.](/juventa-timber-f62c248e90a9/folding-rule-at-rest.webp) ## When the question concerns existing care Questions about an existing Promise request, treatment access or the service’s current process belong with Promise’s own site. Juventa cannot look inside a care request, make a prescribing decision or speak on a pharmacy’s behalf. The [contact page](/contact/) helps separate a reading question from a service question. Personal medical concerns need a licensed provider who can consider the individual circumstances; a page about aging cannot do that work merely by being detailed. ## A question can be the next step. Promise Peptides connects U.S. patients with licensed U.S. providers who examine every request and decide whether prescribing is appropriate. The review may find that a person does not qualify. Access differs with the patient’s state and the treatment. Licensed U.S. compounding pharmacies prepare prescriptions; compounded medicines prepared for these prescriptions are not FDA-approved. [See longevity care with Promise Peptides](https://mypromise.com/solutions/anti-aging-longevity?utm_source=juventa&utm_medium=affiliate&utm_campaign=route&utm_content=how-it-works-closing) Promise’s LegitScript certification does not give a medicine FDA approval. Juventa provides reading and perspective; it has no clinic, no pharmacy and no shop. [Continue to Promise’s own site](https://mypromise.com/?utm_source=juventa&utm_medium=affiliate&utm_campaign=route&utm_content=how-it-works-footer) [Home](/) [What fades](/what-fades/) [NAD+](/nad-plus/) [MOTS-c](/mots-c/) [Sermorelin](/sermorelin/) [GHK-Cu](/ghk-cu/) [Care route](/how-it-works/) [Compare](/compare/) [Questions](/faq/) [About](/about/) [Contact](/contact/) [References](/references/) Juventa Peptides may earn money when readers become Promise patients. Juventa Peptides is an independent guide and is not Promise Peptides. © 2026 Juventa Peptides [Read this page as Markdown](/how-it-works/index.md)